The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

SABCS 2019 Highlights on Metastatic HER2+ Breast Cancer: Outcomes of DS-8201 Trial on Pts Previously Treated With T-DM1 & NALA Trial on Neratinib

199 views
March 12, 2020
Comments 0
Login to view comments. Click here to Login